Edgewise Therapeutics Inc

NASDAQ EWTX

Data sourced from

and

Download Data

Edgewise Therapeutics Inc Selling, General, and Administrative (SG&A) Expense Ratio 1 year YoY Change (%) for the quarter ending September 19, 2024

Edgewise Therapeutics Inc Selling, General, and Administrative (SG&A) Expense Ratio 1 year YoY Change (%) is NA for the quarter ending September 19, 2024. The SG&A expense ratio measures the proportion of selling, general, and administrative (SG&A) expenses to the revenue of a company. It is calculated by dividing the SG&A expenses by the revenue. This ratio indicates the level of SG&A expenses incurred by the company relative to its revenue. A higher ratio suggests a higher allocation of resources towards SG&A expenses, which includes expenses related to sales, marketing, administration, and overhead. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.

NASDAQ: EWTX

Edgewise Therapeutics Inc

CEO	Dr. Kevin Koch Ph.D.
IPO Date	March 26, 2021
Location	United States
Headquarters	3415 Colorado Avenue, Boulder, CO, United States, 80303
Employees	92
Sector	Healthcare
Industry	Biotechnology

Description

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

Key trends